LEADER 00000cam a2200661Ia 4500 
001    879653104 
003    OCoLC 
005    20240129213017.0 
006    m     o  d         
007    cr cn||||||||| 
008    140514s2013    paua    ob    001 0 eng d 
019    864746994 
020    9781908818386 
020    1908818387 
020    9781306177061|q(ebk) 
020    1306177065|q(ebk) 
029 1  DEBBG|bBV042032511 
029 1  DEBSZ|b414179803 
029 1  GBVCP|b814959709 
029 1  AU@|b000054756424 
035    (OCoLC)879653104|z(OCoLC)864746994 
037    CL0500000428|bSafari Books Online 
040    UMI|beng|epn|cUMI|dIDEBK|dGGVRL|dGWM|dDEBBG|dCOO|dOCLCQ
       |dOCLCF|dOCLCO|dCEF|dOCLCA|dAU@|dOCLCO|dOCLCA|dUAB|dSTF
       |dOCLCO|dCASUM|dOCLCA|dOCLCO|dOCLCQ|dINARC|dOCLCO|dOCLCL 
049    INap 
082 04 615.7 
082 04 615.7 
099    eBook O'Reilly for Public Libraries 
100 1  Williams, David R.|q(David Raymond),|d1961-|1https://
       id.oclc.org/worldcat/entity/E39PCjv7v7vmbMQp3RF7hQXQtq 
245 14 The funding of biopharmaceutical research and development 
       /|cDavid R. Williams.|h[O'Reilly electronic resource] 
260    Philadelphia :|bWoodhead Pub.,|c2013. 
300    1 online resource (xxxvii, 245 pages) :|billustrations. 
336    text|btxt|2rdacontent 
337    computer|bc|2rdamedia 
338    online resource|bcr|2rdacarrier 
490 1  Woodhead Publishing Series in biomedicine ;|vno. 43 
504    Includes bibliographical references and index. 
505 0  1. Introduction to the biopharmaceutical market -- 2. 
       Synopsis of theories of the firm and valuation methods -- 
       3. Innovation and the merging of the pharmaceutical and 
       biotechnology industries -- 4. The funding of basic 
       research and public-private partnerships -- 5. Strategic 
       alliances -- 6. Angel and venture capital -- 7. The 
       initial public offering -- 8. Conclusion. 
520    This book describes the theoretical underpinnings, present
       practice, and trends in R & D funding in the human 
       biopharmaceutical market sector, both in the U.S. and 
       worldwide. It includes a review and discussion of public-
       private partnership activity and their inner-workings as 
       well as an overview of the inner-workings of strategic 
       alliance activity, including the advantages and 
       disadvantages for each party. It includes venture capital 
       activity and the IPO process. 
588 0  Print version record. 
590    O'Reilly|bO'Reilly Online Learning: Academic/Public 
       Library Edition 
650  0 Pharmaceutical industry|xFinance. 
650  0 Biopharmaceutics|xResearch. 
650  6 Industrie pharmaceutique|xFinances. 
650  6 Biopharmacie|xRecherche. 
650  7 Pharmaceutical industry|xFinance|2fast 
650 12 Biopharmaceutics|xeconomics 
650 22 Biomedical Research 
650 22 Drug Discovery|xeconomics 
650 22 Drug Industry|xeconomics 
655  4 Internet Resources. 
776 08 |iPrint version:|aWilliams, David R. (David Raymond), 1961
       -|tFunding of biopharmaceutical research and development.
       |dOxford ; Philadelphia : Woodhead Publishing, 2013
       |z9781907568947|w(DLC)  2013940431|w(OCoLC)745979958 
830  0 Woodhead Publishing series in biomedicine ;|vno. 43. 
856 40 |uhttps://ezproxy.naperville-lib.org/login?url=https://
       learning.oreilly.com/library/view/~/9781907568947/?ar
       |zAvailable on O'Reilly for Public Libraries 
938    Internet Archive|bINAR|nfundingofbiophar0000will 
938    Cengage Learning|bGVRL|nGVRL8DEE 
938    ProQuest MyiLibrary Digital eBook Collection|bIDEB
       |ncis26861868 
994    92|bJFN